Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00043693 · ClinicalTrials.gov registry record · NA

Family Intervention for Mental Illness and Substance Abuse

A NA study of Schizophrenia and Bipolar Disorder, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
108
Enrollment target
2
Study locations

NCT00043693 is a NA study of Schizophrenia and Bipolar Disorder that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 108 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00043693, a NA study of Schizophrenia and Bipolar Disorder, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target
2
Study locations

Study Summary

This study will evaluate a family intervention program for individuals with bipolar disorder, schizophrenia, or schizoaffective disorder and co-occurring substance use disorders.

Interventions

  • BEHAVIORAL Family Intervention for Dual Diagnosis
  • BEHAVIORAL Family psychoeducation program

Study Locations (2)

California

  • Pacific Clinics El Camino - Santa Fe Springs

Massachusetts

  • North Suffolk Mental Health Association - Chelsea

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2002-04
Est. Completion 2008-12
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT00043693

The ClinicalTrials.gov registry entry for NCT00043693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (51% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Family Intervention for Dual Diagnosis is the first listed.

NCT00043693 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00043693 about?

NCT00043693 is a clinical study titled "Family Intervention for Mental Illness and Substance Abuse". This study will evaluate a family intervention program for individuals with bipolar disorder, schizophrenia, or schizoaffective disorder and co-occurring substance use disorders.

What is the current status of trial NCT00043693?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2002-04. Estimated completion is 2008-12.

What conditions does trial NCT00043693 study?

This clinical trial studies the following conditions: Schizophrenia, Bipolar Disorder, Substance-Related Disorders.

What interventions are being tested in trial NCT00043693?

The interventions under investigation include: Family Intervention for Dual Diagnosis (BEHAVIORAL), Family psychoeducation program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00043693?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00043693 being conducted?

This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.